These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38709823)

  • 1. CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
    Amorim Sacramento L; Farias Amorim C; G Lombana C; Beiting D; Novais F; P Carvalho L; M Carvalho E; Scott P
    PLoS Pathog; 2024 May; 20(5):e1012211. PubMed ID: 38709823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR5 promotes the migration of CD8
    Sacramento LA; Amorim CF; Lombana CG; Beiting D; Novais F; Carvalho LP; Carvalho EM; Scott P
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor CCR5 correlates with functional CD8
    Wang X; Russell-Lodrigue KE; Ratterree MS; Veazey RS; Xu H
    FASEB J; 2019 Aug; 33(8):8905-8912. PubMed ID: 31034775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis.
    Novais FO; Carvalho LP; Graff JW; Beiting DP; Ruthel G; Roos DS; Betts MR; Goldschmidt MH; Wilson ME; de Oliveira CI; Scott P
    PLoS Pathog; 2013; 9(7):e1003504. PubMed ID: 23874205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence.
    Yurchenko E; Tritt M; Hay V; Shevach EM; Belkaid Y; Piccirillo CA
    J Exp Med; 2006 Oct; 203(11):2451-60. PubMed ID: 17015634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maraviroc attenuates the pathogenesis of experimental autoimmune encephalitis.
    Karampoor S; Zahednasab H; Amini R; Esghaei M; Sholeh M; Keyvani H
    Int Immunopharmacol; 2020 Mar; 80():106138. PubMed ID: 32007705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.
    Belkaid Y; Von Stebut E; Mendez S; Lira R; Caler E; Bertholet S; Udey MC; Sacks D
    J Immunol; 2002 Apr; 168(8):3992-4000. PubMed ID: 11937556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade.
    Kroll-Palhares K; Silvério JC; Silva AA; Michailowsky V; Marino AP; Silva NM; Carvalho CM; Pinto LM; Gazzinelli RT; Lannes-Vieira J
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):375-85. PubMed ID: 18660993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of the CC chemokine receptor 5 (CCR5) on virus-specific CD8+ T cells following coronavirus infection of the central nervous system.
    Glass WG; Lane TE
    Virology; 2003 Aug; 312(2):407-14. PubMed ID: 12919745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection.
    Trifilo MJ; Bergmann CC; Kuziel WA; Lane TE
    J Virol; 2003 Apr; 77(7):4004-14. PubMed ID: 12634360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist.
    Nayak SU; Cicalese S; Tallarida C; Oliver CF; Rawls SM
    Brain Behav Immun; 2020 Jan; 83():288-292. PubMed ID: 31557508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting inhibition of CCR5 on improving obesity-associated insulin resistance and impairment of pancreatic insulin secretion in high fat-fed rodent models.
    Chan PC; Liao MT; Lu CH; Tian YF; Hsieh PS
    Eur J Pharmacol; 2021 Jan; 891():173703. PubMed ID: 33159935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 antagonist treatment inhibits vascular injury by regulating NADPH oxidase 1.
    Singh S; Bruder-Nascimento A; Belin de Chantemele EJ; Bruder-Nascimento T
    Biochem Pharmacol; 2022 Jan; 195():114859. PubMed ID: 34843718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells.
    González-Martín A; Gómez L; Lustgarten J; Mira E; Mañes S
    Cancer Res; 2011 Aug; 71(16):5455-66. PubMed ID: 21715565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic effects of targeting CCR5 and its therapeutic potential for colorectal cancer liver metastasis.
    Pervaiz A; Zepp M; Georges R; Bergmann F; Mahmood S; Faiza S; Berger MR; Adwan H
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):73-91. PubMed ID: 32902795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.
    Casagrande N; Borghese C; Visser L; Mongiat M; Colombatti A; Aldinucci D
    Haematologica; 2019 Mar; 104(3):564-575. PubMed ID: 30309853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2+ and CCR5+ CD8+ T cells increase during viral infection and migrate to sites of infection.
    Nansen A; Marker O; Bartholdy C; Thomsen AR
    Eur J Immunol; 2000 Jul; 30(7):1797-806. PubMed ID: 10940868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.
    Marino AP; da Silva A; dos Santos P; Pinto LM; Gazzinelli RT; Teixeira MM; Lannes-Vieira J
    Circulation; 2004 Sep; 110(11):1443-9. PubMed ID: 15337689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis.
    Sacramento LA; Farias Amorim C; Campos TM; Saldanha M; Arruda S; Carvalho LP; Beiting DP; Carvalho EM; Novais FO; Scott P
    PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011552. PubMed ID: 37603573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNγ(+)-mediated parasite killing in human cutaneous leishmaniasis.
    Santos Cda S; Boaventura V; Ribeiro Cardoso C; Tavares N; Lordelo MJ; Noronha A; Costa J; Borges VM; de Oliveira CI; Van Weyenbergh J; Barral A; Barral-Netto M; Brodskyn CI
    J Invest Dermatol; 2013 Jun; 133(6):1533-40. PubMed ID: 23321919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.